Specialty Pharmacy

A drug used to treat kidney cancer could be effective fighting several types of the disease.

Only 58% of breast cancer survivors received follow-up mammograms in 2007.

Few prior studies have evaluated the relative effectiveness of earlier and later lines of TNF therapy in psoriatic arthritis.

Top news of the week in oncology and cancer drug development.

Researchers found a low-cost approach to examine individual cancer cells, which could lead to a breakthrough in treatments.

Parts of a protein used in some HCV vaccine candidates are far too flexible to be successful.

Researchers seek to improve HIV drug therapies through nanomedicine.

Debiopharm International joins the Merck-Pfizer alliance for non-small cell lung cancer treatment research.

A nonsteroid anti-inflammatory drug used to treat common colds blocks bladder cancer cells from spreading in mice.

Top news of the day from across the health care landscape.

Specially compounded formulations aid patients who require medications that aren’t commercially available.

Effective specialty pharmacy patient assistance programs help patients access and remain adherent to high cost drugs.

Positive results in the KEYNOTE-045 clinical trial of Keytruda showed improved overall survival.

Top news of the day from across the health care landscape.

The widely publicized untested oncology drug scandal could lead to better clinical practice.

Catalent Pharma Solutions and Moderna Therapeutics supports manufacturing of cancer vaccines.

Tennessee pharmacist admits to falsifying prior authorizations, medical lab reports, and drug test results for at least 51 hepatitis C patients prescribed Sovaldi, Harvoni, Viekira Pak, and Daklinza.

Mathematical models and prevention techniques assess viral suppression among HIV-positive men who have sex with men.

First-line pembrolizumab in addition to standard chemotherapy improved response rates and survival in patients with advanced non-small cell lung cancer.

High-risk soft tissue sarcoma patients given anthracycline plus ifosfamide were found to have significant increases in survival.

Pseudomonas aeruginosa causes infections in patients with HIV, cancer, and other immune-compromised disease states.

Top news of the day from across the health care landscape.

Clinicians rely on a limited number of drugs to help patients with type 2 diabetes.

Superior progression-free survival achieved with cabozantinib over sunitinib in patients with metastatic renal cell carcinoma.

Supplements given to prostate cancer patients following radiotherapy could harm disease outcomes.

A component found in red wine and grapes may help manage inflammation caused by a bacterial pathogen associated with upper respiratory tract inflammatory diseases.

Immunotherapy showed promise in first- and second-line therapy for patients with metastatic bladder cancer.

Survey findings show a high level of integration of palliative care in advanced cancer patients.